Venture Life reports extended-period results and prepares founder-CEO handover
Venture Life ($VLG) generated £50 million of continuing-operations revenue and £7.9 million of adjusted EBITDA over its extended 17-month reporting period. On a comparable pro-forma basis, revenue rose 16%. Group profit after tax was £3.4 million, but included £7.2 million from discontinued operations, so it does not indicate a profit from the remaining business. Cash stood at £11.5 million with no borrowings. The company is concentrating on consumer-healthcare brands after earlier manufacturing
0